FindMyKOL
Clinical trialNCT04311515TerminatedPhase 2Interventional

To Evaluate Safety, Tolerability and Pharmacological Effects of PU AD in Subjects With Mild AD Dementia

SponsorSamus Therapeutics, Inc.Enrollment4Alzheimer Disease
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The study is designed as a classic, randomized, double blind, placebo controlled, parallel group study including one active dose of PU AD and matching placebo, designed to assess safety, tolerability and pharmacological effects of oral PU AD (dihydrochloride salt) in subjects with mild AD
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Sfm Clinical Research, Llc

    Boca Raton, Florida, United States

  • Brain Matters Research

    Delray Beach, Florida, United States

  • Jem Research

    Lake Worth, Florida, United States

  • Med-Care Research

    Miami, Florida, United States

  • Miami Dade Medical Research Institute, Llc

    Miami, Florida, United States

  • Neurostudies, Inc

    Port Charlotte, Florida, United States

  • Premiere Research Institute

    West Palm Beach, Florida, United States

  • Conquest Research Llc

    Winter Park, Florida, United States

  • Advanced Clinical Institute, Inc.

    Neptune City, New Jersey, United States

  • Princeton Medical Institute

    Princeton, New Jersey, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

PU-ADPlacebo
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Jun 2020
Primary completion
9 Sept 2020
Completion
15 Nov 2022
Last update posted
17 Nov 2022
Registered enrollment
4
Registry id
NCT04311515
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.